I's this a true statement:Affy has already discussed with takeda and said they were going to have pre- filing meeting with the fda this quarter and file for approval in 2011.The meeting with the FDA is my question: my understanding it's just a guideline on the filing but the fda gives no opinion if they should or not file? It's simple procedure?Just about every biotech I've seen then make a large move upward up to the filing date which would be 2011?Why would affy sell and dilute shareholders at all-time low? They could have got lot higher price in value in the future?I guess my question is on the meeting with the FDA meeting this year? Is it just procedure? Can fda make any negative views like we think you you need more info?